Acta Pharmaceutica Sinica B: 2023, vol: 13, issue: 12
- 1)- Yanping Wang, Weihong Du, Xiaoyan Hu, Xin Yu, Chun Guo, Xinchun Jin, Wei Wang. Targeting the blood-brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4667-4687
Cited : 4Read More - 2)- Jing Ye, Jin Zhang, Yanghui Zhu, Lian Wang, Xian Jiang, Bo Liu, Gu He. Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4688-4714Cited : 6Read More
- 3)- Chuanfeng Liu, Lide Hu, Guanyu Dong, Ying Zhang, Edeildo Ferreira da Silva-Júnior, Xinyong Liu, Luis Menéndez-Arias, Peng Zhan. Emerging drug design strategies in anti-influenza drug discovery. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4715-4732Cited : 2Read More
- 4)- Mingjin Wang, Weida Wang, Shen You, Zhenyan Hou, Ming Ji, Nina Xue, Tingting Du, Xiaoguang Chen, Jing Jin. ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4733-4747Cited : 0Read More
- 5)- Yingqiang Liu, Zhengsheng Zhan, Zhuang Kang, Mengyuan Li, Yongcong Lv, Shenglan Li, Linjiang Tong, Fang Feng, Yan Li, Mengge Zhang, Yaping Xue, Yi Chen, Tao Zhang, Peiran Song, Yi Su, Yanyan Shen, Yiming Sun, Xinying Yang, Yi Chen, Shanyan Yao, Hanyu Yang, Caixia Wang, Meiyu Geng, Wenbin Li, Wenhu Duan, Hua Xie, Jian Ding. Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4748-4764Cited : 2Read More
- 6)- Xuesong Li, Xiang Chen, Longbin Zheng, Minghong Chen, Yunjia Zhang, Ruigong Zhu, Jiajing Chen, Jiaming Gu, Quanwen Yin, Hong Jiang, Xuan Wu, Xian Ji, Xin Tang, Mengdie Dong, Qingguo Li, Yuanqing Gao, Hongshan Chen. Non-canonical STING-PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction integrating IRF3 and NF-B in inflammatory response. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4765-4784Cited : 4Read More
- 7)- Shixin Duan, Xinyi Lou, Shiyi Chen, Hongchao Jiang, Dongxin Chen, Rui Yin, Mengkai Li, Yuseng Gou, Wenjuan Zhao, Lei Sun, Feng Qian. Macrophage LMO7 deficiency facilitates inflammatory injury metabolic-epigenetic reprogramming. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4785-4800Cited : 2Read More
- 8)- Kaikai Zhang, Lijian Chen, Jianzheng Yang, Jiali Liu, Jiahao Li, Yi Liu, Xiuwen Li, Long Chen, Clare Hsu, Jiahao Zeng, Xiaoli Xie, Qi Wang. Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4801-4822Cited : 1Read More
- 9)- Wenjun Yu, Haixia Xu, Zhe Sun, Yuxin Du, Shiqun Sun, Miyesaier Abudureyimu, Mengjiao Zhang, Jun Tao, Junbo Ge, Jun Ren, Yingmei Zhang. TBC1D15 deficiency protects against doxorubicin cardiotoxicity inhibiting DNA-PKcs cytosolic retention and DNA damage. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4823-4839Cited : 1Read More
- 10)- Junting Zhang, Yiying Li, Jianchao Zhang, Lu Liu, Yuan Chen, Xusheng Yang, Xueyi Liao, Muhua He, Zihui Jia, Jun Fan, Jin-Song Bian, Xiaowei Nie. ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through 1-methyladenosine modification of circCDK17. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4840-4855Cited : 1Read More
- 11)- Yong Ke, En Zhang, Jianming Guo, Xiaoxiao Zhang, Lei Wang, Duo Chen, Xinkui Fang, Jianwei Zhu, Feng Li, Tao Sun, Baohong Zhang. Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector (VSV) in golden syrian hamster. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4856-4874Cited : 0Read More
- 12)- Wenjing Yu, Yuehuai Hu, Zhiping Liu, Kaiteng Guo, Dinghu Ma, Mingxia Peng, Yuemei Wang, Jing Zhang, Xiaolei Zhang, Panxia Wang, Jiguo Zhang, Peiqing Liu, Jing Lu. Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy regulation of TFRC-dependent ferroptosis. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4875-4892Cited : 3Read More
- 13)- Youchao Deng, Xiaosheng Song, Iredia D Iyamu, Aiping Dong, Jinrong Min, Rong Huang. A unique binding pocket induced by a noncanonical SAH mimic to develop potent and selective PRMT inhibitors. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4893-4905Cited : 1Read More
- 14)- Li-Min Zhao, Christophe Pannecouque, Erik De Clercq, Shuai Wang, Fen-Er Chen. Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4906-4917Cited : 2Read More
- 15)- Feifei Fang, Yang Dai, Hao Wang, Yinchun Ji, Xuewu Liang, Xia Peng, Jiyuan Li, Yangrong Zhao, Chunpu Li, Danyi Wang, Yazhou Li, Dong Zhang, Dan Zhang, Meiyu Geng, Hong Liu, Jing Ai, Yu Zhou. Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4918-4933Cited : 0Read More
- 16)- Jia-Luo Huang, Xue-Long Yan, Dong Huang, Lu Gan, Huahua Gao, Run-Zhu Fan, Shen Li, Fang-Yu Yuan, Xinying Zhu, Gui-Hua Tang, Hong-Wu Chen, Junjian Wang, Sheng Yin. Discovery of a highly potent and orally available importin-1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4934-4944Cited : 2Read More
- 17)- Xintong Zhao, Jing Feng, Jie Zhang, Zunsheng Han, Yuhua Hu, Hui-Hui Shao, Tianlei Li, Jie Xia, Kangfan Lei, Weiping Wang, Fangfang Lai, Yuan Lin, Bo Liu, Kun Zhang, Chi Zhang, Qingyun Yang, Xinyu Luo, Hanyilan Zhang, Chuang Li, Wenxuan Zhang, Song Wu. Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4945-4962Cited : 1Read More
- 18)- Yubo Wang, Jian Min, Xiangping Deng, Tian Feng, Hebing Hu, Xinyi Guo, Yan Cheng, Baohua Xie, Yu Yang, Chun-Chi Chen, Rey-Ting Guo, Chune Dong, Hai-Bing Zhou. Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4963-4982Cited : 4Read More
- 19)- Yongho Jang, Jeehun Park, Pilsu Kim, Eun-Joo Park, Hyungjin Sun, Yujin Baek, Jaehun Jung, Tai-Kyong Song, Junsang Doh, Hyuncheol Kim. Development of exosome membrane materials-fused microbubbles for enhanced stability and efficient drug delivery of ultrasound contrast agent. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4983-4998Cited : 2Read More
- 20)- Qiaozi Wang, Yanan Song, Jinfeng Gao, Qiyu Li, Jing Chen, Yifang Xie, Zhengmin Wang, Haipeng Tan, Hongbo Yang, Ning Zhang, Juying Qian, Zhiqing Pang, Zheyong Huang, Junbo Ge. Hippo pathway-manipulating neutrophil-mimic hybrid nanoparticles for cardiac ischemic injury modulation of local immunity and cardiac regeneration. Acta pharmaceutica Sinica. B. 2023, 13 (12): 4999-5015Cited : 0Read More
- 21)- Peng Hua, Ruifeng Liang, Yanbei Tu, Yuying Yin, Man-Kay Law, Meiwan Chen. Reactive oxygen species and nitric oxide scavenging nanoparticles alleviating rheumatoid arthritis through adjusting the seeds and growing soils. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5016-5029Cited : 4Read More
- 22)- Huaqing Jing, Yingzi Ren, Yue Zhou, Min Xu, Sona Krizkova, Zbynek Heger, Qiang Lu, Siyu Wang, Xiaoyang Liang, Vojtech Adam, Nan Li. Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5030-5047Cited : 1Read More
- 23)- Xiaodi Liu, Qi Zhang, Yixia Liang, Shiyu Xiong, Yan Cai, Jincheng Cao, Yanni Xu, Xiaolin Xu, Ye Wu, Qiang Lu, Xiaoding Xu, Baoming Luo. Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5048-5059Cited : 1Read More
- 24)- Yitong Liu, Guiyang Xia, Yingyi Chen, Huan Xia, Junji Xu, Lijia Guo, Sheng Lin, Yi Liu. Purpurolide C-based microneedle promotes macrophage-mediated diabetic wound healing inhibiting TLR4-MD2 dimerization and MYD88 phosphorylation. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5060-5073Cited : 2Read More
- 25)- Lina Guo, Jinsong Ding, Wenhu Zhou. Converting bacteria into autologous tumor vaccine surface biomineralization of calcium carbonate for enhanced immunotherapy. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5074-5090Cited : 1Read More
- 26)- Qiujun Qiu, Sunhui Chen, Huining He, Jixiang Chen, Xinyi Ding, Dongdong Wang, Jiangang Yang, Pengcheng Guo, Yang Li, Jisu Kim, Jianyong Sheng, Chao Gao, Bo Yin, Shihao Zheng, Jianxin Wang. An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5091-5106Cited : 2Read More
- 27)- Yan Zhang, Haiyun Zhang, Faquan Zhao, Zhengping Jiang, Yuanlu Cui, Meitong Ou, Lin Mei, Qiangsong Wang. Mitochondrial-targeted and ROS-responsive nanocarrier nose-to-brain pathway for ischemic stroke treatment. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5107-5120Cited : 7Read More
- 28)- Feng Long, Yao Pan, Jinheng Li, Suinan Sha, Xiubo Shi, Haoyan Guo, Chuanqing Huang, Qian Xiao, Chao Fan, Xingmei Zhang, Jun-Bing Fan, Ying Wang. Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect. Acta pharmaceutica Sinica. B. 2023, 13 (12): 5121-5134Cited : 3Read More
